(Stroke. 1999;30:1340-1349.)
© 1999 American Heart Association, Inc.
Original Contributions |
From the Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY.
Correspondence to Robert G. Holloway, University of Rochester School of Medicine and Dentistry, Department of Neurology, 1351 Mt Hope Ave, Suite 216, Rochester, NY 14620. E-mail bholloway{at}mct.rochester.edu
Background and PurposeThis work was undertaken to review research addressing the cost-effectiveness of stroke-related diagnostic, preventive, or therapeutic interventions.
MethodsWe performed searches of MEDLINE, Excerpta Medica online, HealthSTAR, and Sciences Citation Index Expanded and examined the reference lists of the studies and reviews obtained. From these, we selected studies that reported an incremental analysis of cost per effect, in which the effect measure was life-years or quality-adjusted life-years. We abstracted data from each study using a standardized reporting form. Twenty-six articles met the eligibility criteria and were included in the review.
ResultsThe methodological quality of the articles reviewed has improved compared with previously reported. Many stroke evaluation and treatment policies may result in benefits to health that are considered worth their cost. Some interventions were considered cost-ineffective (anticoagulation in low-risk nonvalvular atrial fibrillation and surveillance with duplex ultrasound after endarterectomy). Different studies addressing the cost-effectiveness of screening asymptomatic carotid stenosis resulted in strikingly divergent conclusions, from being cost-effective to being detrimental. Other studies omitted important costs that, if included, would likely have had profound impact on their cost-effectiveness estimates.
ConclusionsGiven the divergent conclusions drawn from studies addressing similar questions, it may be premature to use the results of cost-effectiveness research in developing stroke policy and practice guidelines. Successful implementation of such evaluations in the care of patients with stroke will depend on further standardization of methodology and critical appraisal of reported findings.
Key Words: costs and cost analysis cost-benefit analysis stroke management
This article has been cited by other articles:
![]() |
T. Rundek, K. Nielsen, S. Phillips, K. C. Johnston, M. Hux, D. Watson, and for the GAIN Americas Investigators Health Care Resource Use After Acute Stroke in the Glycine Antagonist in Neuroprotection (GAIN) Americas Trial Stroke, June 1, 2004; 35(6): 1368 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Holloway and A. W. Dick Editorial Comment--Stroke Cost-Effectiveness Research: Are Acceptability Curves Acceptable? Stroke, January 1, 2004; 35(1): 203 - 204. [Full Text] [PDF] |
||||
![]() |
A. Patel, M. Knapp, I. Perez, A. Evans, and L. Kalra Alternative Strategies for Stroke Care: Cost-Effectiveness and Cost-Utility Analyses From a Prospective Randomized Controlled Trial Stroke, January 1, 2004; 35(1): 196 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Goldstein Extracranial Carotid Artery Stenosis Stroke, November 1, 2003; 34(11): 2767 - 2773. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aslanyan, C. J. Weir, K. R. Lees, J. L. Reid, and G. T. McInnes Effect of Area-Based Deprivation on the Severity, Subtype, and Outcome of Ischemic Stroke Stroke, November 1, 2003; 34(11): 2623 - 2628. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Stahl, K. L. Furie, S. Gleason, and G. S. Gazelle Stroke: Effect of Implementing an Evaluation and Treatment Protocol Compliant with NINDS Recommendations Radiology, September 1, 2003; 228(3): 659 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jefferson, V. Demicheli, and L. Vale Quality of Systematic Reviews of Economic Evaluations in Health Care JAMA, June 5, 2002; 287(21): 2809 - 2812. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Benade and C. P. Warlow Costs and Benefits of Carotid Endarterectomy and Associated Preoperative Arterial Imaging: A Systematic Review of Health Economic Literature Stroke, February 1, 2002; 33(2): 629 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Jakovljevic, C. Sarti, J. Sivenius, J. Torppa, M. Mahonen, P. Immonen-Raiha, E. Kaarsalo, K. Alhainen, K. Kuulasmaa, J. Tuomilehto, et al. Socioeconomic Status and Ischemic Stroke : The FINMONICA Stroke Register Stroke, July 1, 2001; 32(7): 1492 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Caro, K. F. Huybrechts, and H. E. Kelley Predicting Treatment Costs After Acute Ischemic Stroke on the Basis of Patient Characteristics at Presentation and Early Dysfunction Stroke, January 1, 2001; 32(1): 100 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Alberts, G. Hademenos, R. E. Latchaw, A. Jagoda, J. R. Marler, M. R. Mayberg, R. D. Starke, H. W. Todd, K. M. Viste, M. Girgus, et al. Recommendations for the Establishment of Primary Stroke Centers JAMA, June 21, 2000; 283(23): 3102 - 3109. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. A. A. Evers, A. J. H. A. Ament, and G. Blaauw Economic Evaluation in Stroke Research : A Systematic Review Stroke, May 1, 2000; 31(5): 1046 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Caro, K. F. Huybrechts, and I. Duchesne Management Patterns and Costs of Acute Ischemic Stroke : An International Study Stroke, March 1, 2000; 31(3): 582 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ebrahim, R. G. Holloway, and C. G. Benesch Systematic Review of Cost-Effectiveness Research of Stroke Evaluation and Treatment • Response Stroke, December 1, 1999; 30(12): 2759 - 2768. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |